Searchable abstracts of presentations at key conferences in endocrinology

ea0004p38 | Diabetes, metabolism and cardiovascular | SFE2002

Sex difference in serum leptin concentrations in Chinese type 2 diabetic patients with or without nephropathy

Chan N , Chan W , Ma R , Ng M , Lee Z , Lai C , Tong P , So W , Chan J

Objectives: To investigate whether there is a sex difference in serum leptin concentration in Chinese Type 2 diabetic patients with and without nephropathy.Methods: Early morning fasting serum leptin concentrations were measured in 34 Type 2 diabetic patients (mean age 62.1) with nephropathy (creatinine 120-450micromol/l and spot urinary albumin creatinine ratio (ACR) > 25 mg/mmol), 12 newly diagnosed diabetic subjects (mean age 62.5) with normoalbumi...

ea0098b8 | Basic Science | NANETS2023

ATRX: a novel predictive biomarker for peptide receptor radionuclide therapy in neuroendocrine tumors

Hammad M. , Lee Z. , Asa S.L. , Aboody K. , Mahipal A. , Bajor D. , Chakrabarti S. , Selfridge J.E. , Ocuin L.M. , Hoehn R.S. , Winter J. , Ammori J. , Hardacre J. , Tirumani S.H. , Henke L.E. , Mohamed A.

Background: Peptide receptor radionuclide therapy (PRRT) including Lutetium177 (Lu177) has changed the treatment landscape of metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs). There is a subgroup of patients who are resistant or develop resistance after initial success to PRRT, indicating that accurate predictive markers are urgently needed to identify who will benefit from PRRT. We hypothesize that expression of ATRX (Alpha Thalassemia and Mental Retardation...